Pulmonary complications in intravenous drug users with and without human immunodeficiency virus co-infection. Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019
C-reactive protein (CRP) levels in children infected with the human immunodeficiency virus (HIV), with and without acute respiratory infection Source: Eur Respir J 2003; 22: Suppl. 45, 142s Year: 2003
The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005
LATE-BREAKING ABSTRACT: Effects of a single treatment with PC786, a novel inhibitor of respiratory syncytial virus replication, on viral load and biomarkers in fully differentiated human bronchial epithelial cells Source: International Congress 2016 – Translational research in respiratory infections Year: 2016
Pulmonary hypertension in human immunodeficiency virus infection Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002
Lack of influx of memory T-cells results in non-reactive tuberculin-skin-test (TST) in HIV-infection Source: Annual Congress 2007 - Immunology and genetics of tuberculosis Year: 2007
Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model Source: Eur Respir J 2011; 38: 401-408 Year: 2011
The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen Source: Eur Respir J 2003; 21: 785-788 Year: 2003
Interferon-dependant and immune cell-based mechanisms of antiviral resistance of the human lung vascular endothelium infected with rhinovirus HRV16 Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Impaired viral clearance after influenza infection in IDO transgenic mice Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005
CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infection Source: Eur Respir J 2001; 18: Suppl. 33, 479s Year: 2001
Lymphocytes mediate the anti-apoptotic effect of respiratory syncytial virus on human neutrophils Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity Year: 2007
Pulmonary disorders and critical care of patients with HIV infection in the era of anti-retrovirals Source: Annual Congress 2006 - MP6 – Pulmonary disorders and critical care of patients with HIV infection in the era of anti-retrovirals Year: 2006
An anti-human ICAM-1 antibody inhibits human rhinovirus infection in the mouse model of human major group rhinovirus infection Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome Source: Eur Respir J 2001; 17: 636-640 Year: 2001
Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells Source: Eur Respir J 2006; 28: 51-58 Year: 2006
Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients Source: Eur Respir J 2002; 20: 28S-39S Year: 2002
LATE-BREAKING ABSTRACT: RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013
RSV and human metapneumovirus – major pathogens of childhood – also adults and the elderly? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005